Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland

ConclusionsOff-label rituximab-treatment can be successfully used to reduce MS disease burden for the benefit of MS patients.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research